abs288.txt	importance		although	clonal	hematopoiesis	(ch)	is	well	described	in	aging	healthypopulations	few	studies	have	addressed	the	practical	clinical	implications	ofthese	alterations	solid-tumor	sequencing	objective	to	identify	and	quantify	ch-related	mutations	patients	with	solidtumors	using	matched	tumor-blood	establish	proportion	thatwould	be	misattributed	tumor	based	on	tumor-only	(unmatchedanalysis)	design	setting	participants	retrospective	analysis	of	samples	from	17	469patients	solid	cancers	who	underwent	prospective	dnaisolated	tissue	peripheral	blood	msk-impactassay	between	january	2014	august	2017	main	outcomes	measures	we	identified	presence	ineach	patient's	leukocytes	quantified	fraction	dna	moleculesharboring	mutation	corresponding	sample	results	mean	age	469	cancer	at	collection	was59	2	years	(range	0	3-98	9	years)	53	6%	were	female	7608ch-associated	4628	(26	5%)	a	total	1075(14	1%)	ch-associated	also	detectable	aboveestablished	thresholds	for	calling	somatic	overall	912	(5	2%)patients	would	had	least	1	erroneously	called	astumor	derived	absence	1061	(98	7%)of	these	absent	population	scale	databases	germlinepolymorphisms	therefore	been	challenging	filter	informatically	annotating	variants	oncokb	classified	534	(49	7%)	as	oncogenic	or	likelyoncogenic	conclusions	relevance	this	study	demonstrates	how	ch-derived	couldlead	erroneous	reporting	treatment	recommendations	when	tumor-onlysequencing	used
